Home
Why Opioids
Ensysce
About Us
Breakthrough
The Solution
Our Science
Beyond Opioids
Pipeline
Road Ahead
Our Team - Executive Management
Board of Directors & Advisors
Our Grants
Home
Executive Management
Board of Directors
Advisory Board
Investors
Our Products
Our Pipeline
Our Technology
Press Releases
Partnering
Contact Us

Ensysce Biosciences

Home
Why Opioids
Ensysce
About Us
Breakthrough
The Solution
Our Science
Beyond Opioids
Pipeline
Road Ahead
Our Team - Executive Management
Board of Directors & Advisors
Our Grants
Home
Executive Management
Board of Directors
Advisory Board
Our Products
Our Pipeline
Our Technology
Partnering
Contact Us

IR Calendar

Investors

Investors

  • Overview
  • News
    • Press Releases
  • Events & Presentations
    • IR Calendar
    • Presentations
  • Leadership
    • Management Team
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Filings and Financials
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Resources
    • Contacts
    • Email Alerts
    • FAQs

  • Events & Presentations

  • IR Calendar
  • Presentations

Ensysce Biosciences, Inc. Corporate Update Call

May 17, 2022 11:00 am EDT
Earnings Release
PDF HTML
Audio
Earnings Webcast
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML
Transcript
PDF
  • Email Alerts
  • Contacts
  • RSS News Feed
Back To Top
Home
About Us
Our Science
Our Team
Contact
ENSYSCE BIOSCIENCES, 7946 Ivanhoe Avenue, LA JOLLA, CA, 92037, United States(858) 263-4196INFO@ENSYSCE.COM
 

Copyright © 2022 Ensysce Biosciences, Inc. All rights reserved.